Plasma-based treatment for chronic wounds shows promise

Over 540 million people worldwide have diabetes, with 30% likely to develop foot ulcers. Treating chronic wounds costs over USD 17 billion annually. Scientists have developed a groundbreaking plasma-based treatment, replacing antibiotics and silver dressings. Plasma-activated hydrogel dressings loaded with reactive oxygen and nitrogen species (RONS) can eradicate bacteria and stimulate the immune system. The treatment holds potential for diabetic foot ulcers, internal wounds, and cancerous tumors. Clinical trials are being prepared.